We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




LAMP Method Detects Malarial Parasites Using Microwave Irradiation

By LabMedica International staff writers
Posted on 10 Dec 2014
Print article
Image: The Blockthermostat BT 200 (Photo courtesy of Kleinfeld Labortechnik).
Image: The Blockthermostat BT 200 (Photo courtesy of Kleinfeld Labortechnik).
A rapid and reliable nucleic acid extraction procedure from human blood and malarial parasites using microwave irradiation as a promising platform has been described.

Although microscopy of blood smears is still considered the gold standard for diagnosing malaria infections, microscopy is frequently unable to detect low-density infections and requires skilled expertise.

Scientists at the University of Tübingen (Germany) working with colleague in the Republic of Congo collected venous blood samples either into 5 mL heparinized tubes or by finger prick with blood stored on sterile Whatman filter paper at admission to the Albert Schweitzer Hospital (Lambaréné, Gabon) from patients suffering from severe Plasmodium falciparum infections.

DNA was extracted from whole blood samples as well as from the cultured parasites of the dilution series using the conventional QIAamp DNA mini blood kit based extraction procedure (Qiagen; Hilden, Germany). A tailored loop mediated isothermal amplification (LAMP) methodology was used that utilized hydroxynaphthol blue (HNB) and Bacillus stearothermophilus (Bst 2.0) DNA polymerases for the molecular detection of malarial parasites. The LAMP assay reactions were performed using two heat blocks (Block Thermostat BT 200, Kleinfeld Labortechnik, Gehrden, Germany) and preheated to 60 °C for DNA amplification for 45 minutes, and enzyme inactivation for two minutes at 80 °C.

Following microwave irradiation for DNA isolation, conventional polymerase chain reaction (PCR) assays were able to detect up to five malaria parasites/µL. The LAMP methodology was capable to detect as low as one P. falciparum parasite/µL after DNA extraction by microwave irradiation. A turnover time of 45 minutes from nucleic acid extraction to final visual read-out was achieved. The amplicon was visualized through a distinct color change and subsequently confirmed by gel electrophoresis. A change from violet to light sky blue was considered a positive result of amplification. If the reaction remained violet, the sample was assessed as being negative.

The authors concluded that the LAMP procedure offers a cheap, simple and fast method of molecular detection of malaria parasites. This test can easily be performed in basic laboratories. The methodology has been validated as a proof of concept and has specifically been developed for use at low-resource settings. Such rapid molecular diagnostic tests may aid health providers to make timely therapeutic interventions in malaria endemic regions. The study was published on November 24, 2014, in the Malaria Journal.

Related Links:
University of Tübingen
Albert Schweitzer Hospital
Kleinfeld Labortechnik


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.